In-Silico Approach for Alpha-Glycosidase and Urease Inhibitor Search - Redhu, Neelam;Khatkar, Anurag
46,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
23 °P sammeln
  • Broschiertes Buch

In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from preclinical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from preclinical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively.
Autorenporträt
Dr. Neelam Redhu has been working on study of microbiology of pathogenic strains and their inhibitor designing and developed several good inhibitors in laboratory. Dr. Anurag Khatkar has been working in Department of Pharmaceutical Sciences, M.D.University, Rohtak and he has published many good papers in high impact journals.